Careers  |  Sign In  |  Register

Acute Myeloid Leukemia Practice Pearls: Key Points in Pathway Identification

In this “Practice Pearls” roundtable organized by Pharmacy Times, expert panelists discuss acute myeloid leukemia (AML) diagnosis and the various factors affecting decision-making for specialists treating patients with AML.

Learn more by clicking here.


  • Katie Culos, PharmD, BCOP
    Hematology/Oncology Clinical Pharmacist – Vanderbilt University Medical Center
    Nashville, Tennessee
  • Amanda Brahim, PharmD, BCOP, BCPS, BCACP
    Hematology/Oncology Clinical Pharmacist – Memorial Cancer Institute
    Pembroke Pines, Florida
  • Yehuda Deutsch, MD
    Hematologist/Oncologist – Department of Malignant Hematology and Cellular Therapy – Memorial Cancer Institute
    Pembroke Pines, Florida


Brian A. Jonas, MD, PhD, FACP
Brian A. Jonas, MD, PhD, FACP

Associate Professor of Medicine

Chair, Hematologic Malignancies Disease Team Committee

Division of Hematology and Oncology

University of California Davis School of Medicine

Sacramento, CA

Gabriel N. Mannis, MD
Gabriel N. Mannis, MD

Assistant Professor of Medicine

Division of Hematology

Stanford Cancer Institute

Stanford University

Stanford, CA